Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	CREBRF JUN JUNB JUND KMT2D MYOD1 MYOG EPAS1	1.54e-05	560	41	8	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	CREBRF JUN JUNB JUND KMT2D MYOD1 MYOG EPAS1	1.66e-05	566	41	8	GO:0001216
GeneOntologyMolecularFunction	chromatin binding	SFMBT1 JDP2 KMT2A JUN CABIN1 MYOD1 MYOG DPPA2	1.10e-04	739	41	8	GO:0003682
GeneOntologyMolecularFunction	RS domain binding	RBM39 SON	1.14e-04	8	41	2	GO:0050733
GeneOntologyMolecularFunction	histone H3K4 monomethyltransferase activity	KMT2A KMT2D	1.14e-04	8	41	2	GO:0140945
GeneOntologyMolecularFunction	histone H3K4 trimethyltransferase activity	KMT2A KMT2D	1.83e-04	10	41	2	GO:0140999
GeneOntologyMolecularFunction	cAMP response element binding	JDP2 JUN	2.68e-04	12	41	2	GO:0035497
GeneOntologyMolecularFunction	U1 snRNP binding	RBM23 RBM39	2.68e-04	12	41	2	GO:1990446
GeneOntologyMolecularFunction	DNA-binding transcription factor activity, RNA polymerase II-specific	CREBRF JDP2 JUN JUNB JUND KMT2D SP110 MYOD1 MYOG EPAS1	4.48e-04	1412	41	10	GO:0000981
GeneOntologyMolecularFunction	snRNP binding	RBM23 RBM39	4.85e-04	16	41	2	GO:0070990
GeneOntologyMolecularFunction	RNA helicase activity	DDX56 DHX37 DHX8	5.49e-04	78	41	3	GO:0003724
GeneOntologyMolecularFunction	ATP-dependent activity, acting on RNA	DDX56 DHX37 DHX8	5.92e-04	80	41	3	GO:0008186
GeneOntologyMolecularFunction	histone H3K4 methyltransferase activity	KMT2A KMT2D	7.63e-04	20	41	2	GO:0042800
GeneOntologyMolecularFunction	transcription factor binding	KMT2A JUN JUNB JUND IFRD1 MYOD1 EPAS1	7.74e-04	753	41	7	GO:0008134
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	KMT2A JUN JUND IFRD1 MYOD1 EPAS1	1.13e-03	582	41	6	GO:0140297
GeneOntologyMolecularFunction	RNA polymerase II-specific DNA-binding transcription factor binding	JUN JUND IFRD1 MYOD1 EPAS1	1.57e-03	417	41	5	GO:0061629
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	KMT2A KMT2D	3.68e-03	44	41	2	GO:0140938
GeneOntologyMolecularFunction	helicase activity	DDX56 DHX37 DHX8	4.16e-03	158	41	3	GO:0004386
GeneOntologyBiologicalProcess	myoblast fate commitment	IFRD1 MYOD1 EPAS1	2.35e-07	7	40	3	GO:0048625
GeneOntologyBiologicalProcess	RNA splicing	PRPF38B SNRNP48 SRSF4 RBM23 MYOD1 RBM39 RSRC1 SON DHX8	3.90e-07	502	40	9	GO:0008380
GeneOntologyBiologicalProcess	mRNA processing	PRPF38B SNRNP48 SRSF4 RBM23 MYOD1 RBM39 RSRC1 SON DHX8	8.48e-07	551	40	9	GO:0006397
GeneOntologyBiologicalProcess	myoblast fate determination	IFRD1 MYOD1	3.67e-06	2	40	2	GO:0007518
GeneOntologyBiologicalProcess	regulation of mRNA splicing, via spliceosome	SRSF4 RBM23 MYOD1 RBM39 SON	4.89e-06	129	40	5	GO:0048024
GeneOntologyBiologicalProcess	mRNA splicing, via spliceosome	SRSF4 RBM23 MYOD1 RBM39 RSRC1 SON DHX8	5.10e-06	358	40	7	GO:0000398
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions with bulged adenosine as nucleophile	SRSF4 RBM23 MYOD1 RBM39 RSRC1 SON DHX8	5.10e-06	358	40	7	GO:0000377
GeneOntologyBiologicalProcess	RNA splicing, via transesterification reactions	SRSF4 RBM23 MYOD1 RBM39 RSRC1 SON DHX8	5.48e-06	362	40	7	GO:0000375
GeneOntologyBiologicalProcess	mRNA metabolic process	PRPF38B SNRNP48 SRSF4 RBM23 MYOD1 RBM39 EPAS1 RSRC1 SON DHX8	7.21e-06	917	40	10	GO:0016071
GeneOntologyBiologicalProcess	regulation of mRNA processing	SRSF4 RBM23 MYOD1 RBM39 SON	1.31e-05	158	40	5	GO:0050684
GeneOntologyBiologicalProcess	RNA processing	ELP1 DDX56 PRPF38B SNRNP48 SRSF4 RBM23 MYOD1 DHX37 RBM39 RSRC1 SON DHX8	1.72e-05	1500	40	12	GO:0006396
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	CREBRF KMT2A JUN JUNB JUND IFRD1 KMT2D ABLIM3 MYOD1 MYOG EPAS1	4.68e-05	1390	40	11	GO:0045944
GeneOntologyBiologicalProcess	regulation of RNA splicing	SRSF4 RBM23 MYOD1 RBM39 SON	4.80e-05	207	40	5	GO:0043484
GeneOntologyBiologicalProcess	positive regulation of skeletal muscle fiber development	MYOD1 MYOG	1.31e-04	9	40	2	GO:0048743
GeneOntologyBiologicalProcess	myoblast differentiation	IFRD1 MYOD1 MYOG EPAS1	1.37e-04	136	40	4	GO:0045445
GeneOntologyBiologicalProcess	chromatin organization	SFMBT1 JDP2 KMT2A KMT2D HIRIP3 CABIN1 DPPA2 MSL3	2.74e-04	896	40	8	GO:0006325
GeneOntologyBiologicalProcess	regulation of skeletal muscle fiber development	MYOD1 MYOG	3.29e-04	14	40	2	GO:0048742
GeneOntologyBiologicalProcess	muscle cell fate commitment	MYOD1 MYOG	5.50e-04	18	40	2	GO:0042693
GeneOntologyBiologicalProcess	protein-DNA complex organization	SFMBT1 JDP2 KMT2A KMT2D HIRIP3 CABIN1 DPPA2 MSL3	5.68e-04	999	40	8	GO:0071824
GeneOntologyBiologicalProcess	cellular response to calcium ion	JUN JUNB JUND	6.61e-04	88	40	3	GO:0071277
GeneOntologyBiologicalProcess	cellular response to metal ion	JUN JUNB JUND MYOG	8.37e-04	219	40	4	GO:0071248
GeneOntologyBiologicalProcess	positive regulation of skeletal muscle tissue development	MYOD1 MYOG	1.07e-03	25	40	2	GO:0048643
GeneOntologyBiologicalProcess	regulation of myoblast fusion	MYOD1 MYOG	1.07e-03	25	40	2	GO:1901739
GeneOntologyCellularComponent	transcription factor AP-1 complex	JUN JUNB JUND	6.98e-08	5	41	3	GO:0035976
GeneOntologyCellularComponent	transcription regulator complex	JDP2 JUN JUNB JUND MYOD1 MYOG EPAS1	1.43e-04	596	41	7	GO:0005667
GeneOntologyCellularComponent	nuclear protein-containing complex	JDP2 KMT2A JUN JUNB JUND PRPF38B SNRNP48 KMT2D DHX8	1.17e-03	1377	41	9	GO:0140513
GeneOntologyCellularComponent	nuclear speck	SRSF4 RBM39 EPAS1 RSRC1 SON	1.48e-03	431	41	5	GO:0016607
GeneOntologyCellularComponent	nuclear body	CREBRF SRSF4 RBM39 EPAS1 RSRC1 SON DHX8	1.70e-03	903	41	7	GO:0016604
GeneOntologyCellularComponent	RNA polymerase II transcription regulator complex	JDP2 JUN JUNB JUND	1.94e-03	272	41	4	GO:0090575
HumanPheno	Broad lateral eyebrow	KMT2A SON	2.77e-05	3	16	2	HP:0007933
HumanPheno	Decreased proportion of memory B cells	KMT2D SP110 MAP3K14	7.10e-05	27	16	3	HP:0030374
HumanPheno	Abnormal proportion of memory B cells	KMT2D SP110 MAP3K14	7.10e-05	27	16	3	HP:0030373
HumanPheno	Abnormal B cell subset distribution	KMT2D SP110 MAP3K14	1.08e-04	31	16	3	HP:0025539
HumanPheno	Hyperextensibility at elbow	KMT2A SON	1.38e-04	6	16	2	HP:0010485
HumanPheno	Eversion of lateral third of lower eyelids	KMT2A KMT2D	1.38e-04	6	16	2	HP:0007655
Domain	Jun	JUN JUNB JUND	7.77e-09	3	38	3	PF03957
Domain	JNK	JUN JUNB JUND	7.77e-09	3	38	3	IPR005643
Domain	Leuzip_Jun	JUN JUNB JUND	7.77e-09	3	38	3	IPR002112
Domain	BZIP_BASIC	CREBRF JDP2 JUN JUNB JUND	7.09e-08	53	38	5	PS00036
Domain	bZIP	CREBRF JDP2 JUN JUNB JUND	7.80e-08	54	38	5	IPR004827
Domain	bZIP_1	JDP2 JUN JUNB JUND	6.47e-07	34	38	4	PF00170
Domain	BRLZ	JDP2 JUN JUNB JUND	3.68e-06	52	38	4	SM00338
Domain	BZIP	JDP2 JUN JUNB JUND	3.97e-06	53	38	4	PS50217
Domain	RBM39linker	RBM23 RBM39	4.03e-06	2	38	2	PF15519
Domain	RBM39_SF	RBM23 RBM39	4.03e-06	2	38	2	IPR006509
Domain	RBM39_linker	RBM23 RBM39	4.03e-06	2	38	2	IPR029123
Domain	-	JUN JUNB JUND	4.27e-06	16	38	3	1.10.880.10
Domain	Basic	MYOD1 MYOG	2.41e-05	4	38	2	IPR002546
Domain	BASIC	MYOD1 MYOG	2.41e-05	4	38	2	SM00520
Domain	Basic	MYOD1 MYOG	2.41e-05	4	38	2	PF01586
Domain	FYrich_C	KMT2A KMT2D	4.02e-05	5	38	2	IPR003889
Domain	FYrich_N	KMT2A KMT2D	4.02e-05	5	38	2	IPR003888
Domain	FYRC	KMT2A KMT2D	4.02e-05	5	38	2	SM00542
Domain	FYRN	KMT2A KMT2D	4.02e-05	5	38	2	SM00541
Domain	FYRN	KMT2A KMT2D	4.02e-05	5	38	2	PF05964
Domain	FYRC	KMT2A KMT2D	4.02e-05	5	38	2	PF05965
Domain	FYRC	KMT2A KMT2D	4.02e-05	5	38	2	PS51543
Domain	FYRN	KMT2A KMT2D	4.02e-05	5	38	2	PS51542
Domain	TF_DNA-bd	JUN JUNB JUND	5.76e-05	37	38	3	IPR008917
Domain	DEAD	DDX56 DHX37 DHX8	4.38e-04	73	38	3	PF00270
Domain	DEAD/DEAH_box_helicase_dom	DDX56 DHX37 DHX8	4.38e-04	73	38	3	IPR011545
Domain	PHD	KMT2A KMT2D SP110	4.74e-04	75	38	3	PF00628
Domain	Post-SET_dom	KMT2A KMT2D	4.75e-04	16	38	2	IPR003616
Domain	PostSET	KMT2A KMT2D	4.75e-04	16	38	2	SM00508
Domain	POST_SET	KMT2A KMT2D	4.75e-04	16	38	2	PS50868
Domain	DUF1605	DHX37 DHX8	5.38e-04	17	38	2	IPR011709
Domain	OB_NTP_bind	DHX37 DHX8	5.38e-04	17	38	2	PF07717
Domain	Znf_PHD-finger	KMT2A KMT2D SP110	5.52e-04	79	38	3	IPR019787
Domain	HA2	DHX37 DHX8	6.04e-04	18	38	2	PF04408
Domain	Helicase-assoc_dom	DHX37 DHX8	6.04e-04	18	38	2	IPR007502
Domain	HA2	DHX37 DHX8	6.04e-04	18	38	2	SM00847
Domain	PHD	KMT2A KMT2D SP110	7.82e-04	89	38	3	SM00249
Domain	Znf_PHD	KMT2A KMT2D SP110	8.34e-04	91	38	3	IPR001965
Domain	EPHD	KMT2A KMT2D	9.08e-04	22	38	2	PS51805
Domain	ZF_PHD_2	KMT2A KMT2D SP110	9.45e-04	95	38	3	PS50016
Domain	ZF_PHD_1	KMT2A KMT2D SP110	9.74e-04	96	38	3	PS01359
Domain	Helicase_C	DDX56 DHX37 DHX8	1.33e-03	107	38	3	PF00271
Domain	HELICc	DDX56 DHX37 DHX8	1.33e-03	107	38	3	SM00490
Domain	Helicase_C	DDX56 DHX37 DHX8	1.37e-03	108	38	3	IPR001650
Domain	HELICASE_CTER	DDX56 DHX37 DHX8	1.41e-03	109	38	3	PS51194
Domain	HELICASE_ATP_BIND_1	DDX56 DHX37 DHX8	1.41e-03	109	38	3	PS51192
Domain	DEXDc	DDX56 DHX37 DHX8	1.41e-03	109	38	3	SM00487
Domain	Helicase_ATP-bd	DDX56 DHX37 DHX8	1.44e-03	110	38	3	IPR014001
Domain	HLH	MYOD1 MYOG EPAS1	1.48e-03	111	38	3	PF00010
Domain	HLH	MYOD1 MYOG EPAS1	1.68e-03	116	38	3	SM00353
Domain	BHLH	MYOD1 MYOG EPAS1	1.72e-03	117	38	3	PS50888
Domain	bHLH_dom	MYOD1 MYOG EPAS1	1.77e-03	118	38	3	IPR011598
Domain	DNA/RNA_helicase_DEAH_CS	DHX37 DHX8	2.30e-03	35	38	2	IPR002464
Domain	DEAH_ATP_HELICASE	DHX37 DHX8	2.71e-03	38	38	2	PS00690
Domain	BROMODOMAIN_2	KMT2A SP110	3.14e-03	41	38	2	PS50014
Domain	SET	KMT2A KMT2D	3.14e-03	41	38	2	PF00856
Domain	Znf_FYVE_PHD	KMT2A KMT2D SP110	3.29e-03	147	38	3	IPR011011
Domain	BROMO	KMT2A SP110	3.30e-03	42	38	2	SM00297
Domain	Bromodomain	KMT2A SP110	3.30e-03	42	38	2	IPR001487
Domain	-	KMT2A SP110	3.30e-03	42	38	2	1.20.920.10
Domain	SET	KMT2A KMT2D	3.94e-03	46	38	2	SM00317
Domain	SET_dom	KMT2A KMT2D	4.64e-03	50	38	2	IPR001214
Domain	SET	KMT2A KMT2D	4.64e-03	50	38	2	PS50280
Pathway	WP_OSTEOARTHRITIC_CHONDROCYTE_HYPERTROPHY	JUN JUNB JUND EPAS1	6.76e-06	50	35	4	M48087
Pathway	PID_ATF2_PATHWAY	JDP2 JUN JUNB JUND	1.32e-05	59	35	4	M166
Pathway	WP_HYPERTROPHY_MODEL	JUND IFRD1 MYOG	1.32e-05	19	35	3	MM15938
Pathway	WP_HYPERTROPHY_MODEL	JUND IFRD1 MYOG	1.55e-05	20	35	3	M39674
Pathway	PID_TCR_CALCIUM_PATHWAY	JUN JUNB CABIN1	4.40e-05	28	35	3	M235
Pathway	PID_FRA_PATHWAY	JUN JUNB JUND	1.03e-04	37	35	3	M65
Pathway	WP_ARYL_HYDROCARBON_RECEPTOR_PATHWAY_WP2873	JUN JUNB JUND	1.85e-04	45	35	3	M39615
Pathway	WP_HYPOXIADEPENDENT_SELFRENEWAL_OF_MYOBLASTS	MYOD1 MYOG	5.35e-04	14	35	2	MM15832
Pathway	BIOCARTA_CD40_PATHWAY	ELP1 MAP3K14	6.16e-04	15	35	2	M16697
Pathway	PID_AP1_PATHWAY	JUN JUNB JUND	6.85e-04	70	35	3	M167
Pathway	WP_MRNA_PROCESSING	DDX56 SRSF4 RSRC2 RBM39 SON DHX8	7.65e-04	451	35	6	MM15946
Pathway	BIOCARTA_TNFR2_PATHWAY	ELP1 MAP3K14	7.96e-04	17	35	2	M10082
Pathway	BIOCARTA_TNFR2_PATHWAY	ELP1 MAP3K14	7.96e-04	17	35	2	MM1517
Pathway	WP_PATHOPHYSIOLOGICAL_ROLES_OF_DUX4_IN_FSHD1	MYOD1 MYOG	8.94e-04	18	35	2	M48069
Pathway	WP_HYPOXIADEPENDENT_PROLIFERATION_OF_MYOBLASTS	MYOD1 MYOG	9.97e-04	19	35	2	MM15811
Pathway	BIOCARTA_TOLL_PATHWAY	JUN MAP3K14	1.60e-03	24	35	2	MM1518
Pathway	BIOCARTA_STRESS_PATHWAY	JUN MAP3K14	1.60e-03	24	35	2	MM1515
Pathway	REACTOME_MYOGENESIS	MYOD1 MYOG	1.60e-03	24	35	2	MM15174
Pathway	BIOCARTA_STRESS_PATHWAY	JUN MAP3K14	1.60e-03	24	35	2	M9670
Pathway	WP_NOVEL_JUNDMP1_PATHWAY	JUN JUNB	1.73e-03	25	35	2	MM15984
Pathway	BIOCARTA_HDAC_PATHWAY	CABIN1 MYOD1	1.73e-03	25	35	2	M1547
Pathway	BIOCARTA_TOLL_PATHWAY	JUN MAP3K14	1.73e-03	25	35	2	M984
Pathway	REACTOME_MRNA_SPLICING	SNRNP48 SRSF4 RBM39 DHX8	1.81e-03	212	35	4	M14033
Pathway	BIOCARTA_HDAC_PATHWAY	CABIN1 MYOD1	1.87e-03	26	35	2	MM1371
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	SFMBT1 JDP2 KMT2A JUN JUNB DDX56 JUND KMT2D SRSF4 HIRIP3 CABIN1 SP110 RBM39 RSRC1 SON DHX8 MSL3	2.95e-14	1294	41	17	30804502
Pubmed	Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions.	JDP2 JUN JUNB JUND	1.66e-12	4	41	4	9154808
Pubmed	IRF2-binding protein-1 is a JDP2 ubiquitin ligase and an inhibitor of ATF2-dependent transcription.	JDP2 JUN JUNB JUND	5.80e-11	7	41	4	18671972
Pubmed	The protein interaction landscape of the human CMGC kinase group.	SFMBT1 JUN SRSF4 RSRC2 HIRIP3 RBM23 RBM39 RSRC1 SON DHX8 MSL3	3.44e-10	695	41	11	23602568
Pubmed	DNA binding activities of three murine Jun proteins: stimulation by Fos.	JUN JUNB JUND	1.52e-09	3	41	3	3142691
Pubmed	Different members of the jun proto-oncogene family exhibit distinct patterns of expression in response to type beta transforming growth factor.	JUN JUNB JUND	1.52e-09	3	41	3	2104845
Pubmed	junD mRNA expression differs from c-jun and junB mRNA expression during male germinal cell differentiation.	JUN JUNB JUND	1.52e-09	3	41	3	1793595
Pubmed	Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells.	JUN JUNB JUND MYOD1	5.02e-09	18	41	4	19303854
Pubmed	A census of human transcription factors: function, expression and evolution.	CREBRF JDP2 KMT2A JUN JUNB JUND KMT2D SP110 MYOD1 MYOG EPAS1	5.59e-09	908	41	11	19274049
Pubmed	c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions.	JUN JUNB JUND	6.08e-09	4	41	3	8945519
Pubmed	JunB potentiates function of BRCA1 activation domain 1 (AD1) through a coiled-coil-mediated interaction.	JUN JUNB JUND	6.08e-09	4	41	3	12080089
Pubmed	Genetic background influences embryonic lethality and the occurrence of neural tube defects in Men1 null mice: relevance to genetic modifiers.	JUN JUNB JUND	6.08e-09	4	41	3	19587266
Pubmed	Inhibition of the JNK/MAPK signaling pathway by myogenesis-associated miRNAs is required for skeletal muscle development.	JUN MYOD1 MYOG	6.08e-09	4	41	3	29449644
Pubmed	Heterodimerization with Jun family members regulates c-Fos nucleocytoplasmic traffic.	JUN JUNB JUND	6.08e-09	4	41	3	17681951
Pubmed	Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene.	JUN JUNB JUND	1.52e-08	5	41	3	12165517
Pubmed	Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1.	JUN JUNB JUND	1.52e-08	5	41	3	1605850
Pubmed	Constitutive expression of the AP-1 transcription factors c-jun, junD, junB, and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma.	JUN JUNB JUND	1.52e-08	5	41	3	15507668
Pubmed	Biphasic regulation of AP-1 subunits during human epidermal wound healing.	JUN JUNB JUND	1.52e-08	5	41	3	17495958
Pubmed	The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.	JUN JUNB JUND	1.52e-08	5	41	3	8617242
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	KMT2A FAM91A1 JUN JUNB JUND PRPF38B KMT2D HIRIP3 SON MSL3	1.69e-08	774	41	10	15302935
Pubmed	Tissue-specific expression of the fos-related transcription factor fra-2 during mouse development.	JUN JUNB JUND	3.03e-08	6	41	3	7700631
Pubmed	Presenilin 1 suppresses the function of c-Jun homodimers via interaction with QM/Jif-1.	JUN JUNB JUND	3.03e-08	6	41	3	10508860
Pubmed	The same pocket in menin binds both MLL and JUND but has opposite effects on transcription.	KMT2A JUN JUND	3.03e-08	6	41	3	22327296
Pubmed	Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cells.	JUN JUNB JUND	3.03e-08	6	41	3	24029232
Pubmed	Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes.	JUN JUNB JUND	3.03e-08	6	41	3	9872330
Pubmed	B-ATF: a novel human bZIP protein that associates with members of the AP-1 transcription factor family.	JUN JUNB JUND	3.03e-08	6	41	3	8570175
Pubmed	Characterization of the physical interaction between estrogen receptor alpha and JUN proteins.	JUN JUNB JUND	5.30e-08	7	41	3	11477071
Pubmed	Genetic mapping in the mouse of four loci related to the jun family of transcriptional activators.	JUN JUNB JUND	5.30e-08	7	41	3	1887331
Pubmed	Chromosomal localization of the three members of the jun proto-oncogene family in mouse and man.	JUN JUNB JUND	5.30e-08	7	41	3	2108401
Pubmed	Smads bind directly to the Jun family of AP-1 transcription factors.	JUN JUNB JUND	5.30e-08	7	41	3	10220381
Pubmed	Coactivation of nuclear receptors and myogenic factors induces the major BTG1 influence on muscle differentiation.	JUN MYOD1 MYOG	8.48e-08	8	41	3	15674337
Pubmed	CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas.	JUN JUNB JUND	8.48e-08	8	41	3	26747248
Pubmed	Binding site specificity and factor redundancy in activator protein-1-driven human papillomavirus chromatin-dependent transcription.	JUN JUNB JUND	8.48e-08	8	41	3	21937452
Pubmed	Selective interaction of JNK protein kinase isoforms with transcription factors.	JUN JUNB JUND	8.48e-08	8	41	3	8654373
Pubmed	Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.	JUN JUNB JUND	1.81e-07	10	41	3	24411941
Pubmed	A novel SR-related protein is required for the second step of Pre-mRNA splicing.	RBM39 RSRC1 SON	3.32e-07	12	41	3	15798186
Pubmed	SETD1A Methyltransferase Is Physically and Functionally Linked to the DNA Damage Repair Protein RAD18.	KMT2A PRPF38B SNRNP48 KMT2D SRSF4 HIRIP3	4.84e-07	251	41	6	31076518
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	KMT2A DDX56 JUND SRSF4 DHX37 RBM39 RSRC1 SON DHX8	5.03e-07	847	41	9	35850772
Pubmed	Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes.	SFMBT1 JDP2 JUN JUNB JUND IFRD1 KMT2D RSRC2 CABIN1	5.55e-07	857	41	9	25609649
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	ELP1 KMT2A DDX56 SRSF4 DHX37 RBM39 SON DHX8	8.19e-07	653	41	8	22586326
Pubmed	Functions of c-Jun in liver and heart development.	JUN JUNB JUND	8.42e-07	16	41	3	10352021
Pubmed	Identification of bipotent progenitors that give rise to myogenic and connective tissues in mouse.	SCUBE1 MYOD1 MYOG	8.42e-07	16	41	3	35225230
Pubmed	Cell-free cotranslation and selection using in vitro virus for high-throughput analysis of protein-protein interactions and complexes.	JUN JUNB JUND	8.42e-07	16	41	3	15867431
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	KMT2A FAM91A1 JUNB DDX56 PRPF38B IFRD1 RSRC2 RBM23 RSRC1 SON DHX8	8.68e-07	1497	41	11	31527615
Pubmed	Jun and JunD-dependent functions in cell proliferation and stress response.	JUN JUNB JUND	1.02e-06	17	41	3	20300111
Pubmed	Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins.	JUN JUNB JUND	1.23e-06	18	41	3	9858769
Pubmed	Isolation of human cDNA clones of jun-related genes, jun-B and jun-D.	JUNB JUND	1.36e-06	2	41	2	2112242
Pubmed	MyoD and myogenin are coexpressed in regenerating skeletal muscle of the mouse.	MYOD1 MYOG	1.36e-06	2	41	2	1311614
Pubmed	Myogenic determination and differentiation of the mouse palatal muscle in relation to the developing mandibular nerve.	MYOD1 MYOG	1.36e-06	2	41	2	10439029
Pubmed	Growth factor responsiveness: role of MyoD and myogenin.	MYOD1 MYOG	1.36e-06	2	41	2	1324843
Pubmed	Expression of c-jun, jun B and jun D proto-oncogenes in human peripheral-blood granulocytes.	JUNB JUND	1.36e-06	2	41	2	1899335
Pubmed	PC4/Tis7/IFRD1 stimulates skeletal muscle regeneration and is involved in myoblast differentiation as a regulator of MyoD and NF-kappaB.	IFRD1 MYOD1	1.36e-06	2	41	2	21127072
Pubmed	An initial blueprint for myogenic differentiation.	MYOD1 MYOG	1.36e-06	2	41	2	15706034
Pubmed	Global and gene-specific analyses show distinct roles for Myod and Myog at a common set of promoters.	MYOD1 MYOG	1.36e-06	2	41	2	16437161
Pubmed	m6A RNA methylation regulates the transcription factors JUN and JUNB in TGF-β-induced epithelial-mesenchymal transition of lung cancer cells.	JUN JUNB	1.36e-06	2	41	2	36183833
Pubmed	Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasis.	JUN JUNB	1.36e-06	2	41	2	19995970
Pubmed	Inhibiting an RBM39/MLL1 epigenomic regulatory complex with dominant-negative peptides disrupts cancer cell transcription and proliferation.	KMT2A RBM39	1.36e-06	2	41	2	34077726
Pubmed	Decreased Jun-D and myogenin expression in muscle wasting of human cachexia.	JUND MYOG	1.36e-06	2	41	2	19470832
Pubmed	Dithranol targets keratinocytes, their crosstalk with neutrophils and inhibits the IL-36 inflammatory loop in psoriasis.	JUN JUNB	1.36e-06	2	41	2	32484435
Pubmed	eRNAs promote transcription by establishing chromatin accessibility at defined genomic loci.	MYOD1 MYOG	1.36e-06	2	41	2	23993744
Pubmed	Insights into interplay between rexinoid signaling and myogenic regulatory factor-associated chromatin state in myogenic differentiation.	MYOD1 MYOG	1.36e-06	2	41	2	28981706
Pubmed	Human MyoD: cDNA and deduced amino acid sequence.	MYOD1 MYOG	1.36e-06	2	41	2	1850513
Pubmed	The transcription factor c-Jun inhibits RBM39 to reprogram pre-mRNA splicing during genotoxic stress.	JUN RBM39	1.36e-06	2	41	2	36477312
Pubmed	JunD and JunB integrate prostaglandin E2 activation of breast cancer-associated proximal aromatase promoters.	JUNB JUND	1.36e-06	2	41	2	21393445
Pubmed	Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products.	MYOD1 MYOG	1.36e-06	2	41	2	2583111
Pubmed	Adipocyte differentiation selectively represses the serum inducibility of c-jun and junB by reversible transcription-dependent mechanisms.	JUN JUNB	1.36e-06	2	41	2	8197114
Pubmed	c-Jun and JunB are essential for hypoglycemia-mediated VEGF induction.	JUN JUNB	1.36e-06	2	41	2	17341624
Pubmed	c-Jun promotes whereas JunB inhibits epidermal neoplasia.	JUN JUNB	1.36e-06	2	41	2	21289643
Pubmed	Set1 and MLL1/2 Target Distinct Sets of Functionally Different Genomic Loci In Vivo.	KMT2A KMT2D	1.36e-06	2	41	2	26711341
Pubmed	Cooperation of MLL1 and Jun in controlling H3K4me3 on enhancers in colorectal cancer.	KMT2A JUN	1.36e-06	2	41	2	38012744
Pubmed	Unprocessed myogenin transcripts accumulate during mouse embryogenesis.	MYOD1 MYOG	1.36e-06	2	41	2	8294401
Pubmed	Mll2 is required for H3K4 trimethylation on bivalent promoters in embryonic stem cells, whereas Mll1 is redundant.	KMT2A KMT2D	1.36e-06	2	41	2	24423662
Pubmed	Unifying mechanism for different fibrotic diseases.	JUN JUNB	1.36e-06	2	41	2	28424250
Pubmed	Cleavage of the JunB transcription factor by caspases generates a carboxyl-terminal fragment that inhibits activator protein-1 transcriptional activity.	JUN JUNB	1.36e-06	2	41	2	23749999
Pubmed	The prognostic significance of Jun transcription factors in ovarian cancer.	JUN JUND	1.36e-06	2	41	2	23942796
Pubmed	Cloning of human acetyl-CoA carboxylase beta promoter and its regulation by muscle regulatory factors.	MYOD1 MYOG	1.36e-06	2	41	2	11076940
Pubmed	Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: a Children's Oncology Group study.	MYOD1 MYOG	1.36e-06	2	41	2	17378682
Pubmed	Inositoylated platelet-activating factor (Ino-C2-PAF) modulates dynamic lymphocyte-endothelial cell interactions and alleviates psoriasis-like skin inflammation in two complementary mouse models.	JUN JUNB	1.36e-06	2	41	2	24714204
Pubmed	Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.	JUN JUNB	1.36e-06	2	41	2	15240010
Pubmed	Transcription factors junB and c-jun are selectively up-regulated and functionally implicated in fibrosarcoma development.	JUN JUNB	1.36e-06	2	41	2	1459456
Pubmed	Functional antagonism between c-Jun and MyoD proteins: a direct physical association.	JUN MYOD1	1.36e-06	2	41	2	1310896
Pubmed	A gene activated by growth factors is related to the oncogene v-jun.	JUN JUNB	1.36e-06	2	41	2	3422745
Pubmed	The expression of HIV-1 Vpu in monocytes causes increased secretion of TGF-β that activates profibrogenic genes in hepatic stellate cells.	JUN JUNB JUND	1.45e-06	19	41	3	24551192
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	DDX56 PRPF38B SRSF4 RSRC2 RBM39 RSRC1 SON DHX8	1.58e-06	713	41	8	29802200
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	ELP1 KMT2A FAM91A1 DDX56 PRPF38B RSRC2 RBM23 DHX37 RSRC1 SON	3.22e-06	1371	41	10	36244648
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	DDX56 PRPF38B SNRNP48 SRSF4 RSRC2 DHX37 RBM39 SON DHX8	3.77e-06	1082	41	9	38697112
Pubmed	Inhibition of BATF/JUN transcriptional activity protects against osteoarthritic cartilage destruction.	JUN JUNB	4.06e-06	3	41	2	27147707
Pubmed	PRMT1 activates myogenin transcription via MyoD arginine methylation at R121.	MYOD1 MYOG	4.06e-06	3	41	2	31634638
Pubmed	Differential mechanisms of transcriptional regulation of the mouse osteocalcin gene by Jun family members.	JUN JUND	4.06e-06	3	41	2	17308994
Pubmed	A new group of conserved coactivators that increase the specificity of AP-1 transcription factors.	JUN JUND	4.06e-06	3	41	2	8837781
Pubmed	Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease.	JUN JUNB	4.06e-06	3	41	2	35788494
Pubmed	Loss of JUNB/AP-1 promotes invasive prostate cancer.	JUN JUNB	4.06e-06	3	41	2	25526087
Pubmed	ADAR1 deaminase contributes to scheduled skeletal myogenesis progression via stage-specific functions.	MYOD1 MYOG	4.06e-06	3	41	2	24440912
Pubmed	Specific roles for dendritic cell subsets during initiation and progression of psoriasis.	JUN JUNB	4.06e-06	3	41	2	25216727
Pubmed	Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential.	MYOD1 MYOG	4.06e-06	3	41	2	15149596
Pubmed	JunB and JunD regulate human heme oxygenase-1 gene expression in renal epithelial cells.	JUNB JUND	4.06e-06	3	41	2	17204476
Pubmed	SON and Its Alternatively Spliced Isoforms Control MLL Complex-Mediated H3K4me3 and Transcription of Leukemia-Associated Genes.	KMT2A SON	4.06e-06	3	41	2	26990989
Pubmed	Pygo2 functions as a prognostic factor for glioma due to its up-regulation of H3K4me3 and promotion of MLL1/MLL2 complex recruitment.	KMT2A KMT2D	4.06e-06	3	41	2	26902498
Pubmed	S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3.	JUN JUNB	4.06e-06	3	41	2	24332034
Pubmed	Tumor necrosis factor-alpha inhibits transforming growth factor-beta /Smad signaling in human dermal fibroblasts via AP-1 activation.	JUN JUNB	4.06e-06	3	41	2	10903323
Interaction	SRPK1 interactions	SFMBT1 SRSF4 RSRC2 HIRIP3 RBM23 RBM39 RSRC1 SON DHX8 MAP3K14	2.92e-08	477	41	10	int:SRPK1
Interaction	BATF interactions	JUN JUNB JUND EPAS1	1.52e-07	24	41	4	int:BATF
Interaction	JMJD6 interactions	PRPF38B RSRC2 RBM23 RBM39 RSRC1 SON DHX8	1.71e-07	205	41	7	int:JMJD6
Interaction	EP300 interactions	ELP1 JDP2 JUN JUNB DDX56 JUND IFRD1 KMT2D SRSF4 RBM23 MYOD1 RBM39 EPAS1 SON	3.42e-07	1401	41	14	int:EP300
Interaction	MEF2A interactions	JUN JUND CABIN1 MYOD1 MYOG	4.50e-07	76	41	5	int:MEF2A
Interaction	SRPK2 interactions	DDX56 PRPF38B SRSF4 RSRC2 HIRIP3 RBM23 RBM39 RSRC1 SON DHX8	1.26e-06	717	41	10	int:SRPK2
Interaction	JDP2 interactions	JDP2 JUN JUNB JUND	1.56e-06	42	41	4	int:JDP2
Interaction	IFI6 interactions	PRPF38B RSRC2 CABIN1 RSRC1	4.33e-06	54	41	4	int:IFI6
Interaction	MEF2C interactions	IFRD1 MYOD1 MYOG EPAS1	4.33e-06	54	41	4	int:MEF2C
Interaction	BATF3 interactions	JUN JUNB JUND EPAS1	4.33e-06	54	41	4	int:BATF3
Interaction	DDIT3 interactions	JDP2 JUN JUNB JUND EPAS1	4.35e-06	120	41	5	int:DDIT3
Interaction	SRSF6 interactions	KMT2A DDX56 PRPF38B SRSF4 RBM23 RBM39 SON DHX8	6.59e-06	503	41	8	int:SRSF6
Interaction	CD2BP2 interactions	CREBRF PRPF38B SRSF4 RBM39 RSRC1 DHX8	7.00e-06	232	41	6	int:CD2BP2
Interaction	DBP interactions	JDP2 KMT2A EPAS1	7.40e-06	19	41	3	int:DBP
Interaction	ZCCHC10 interactions	SFMBT1 CABIN1 RBM39 SON DHX8 DPPA2	7.72e-06	236	41	6	int:ZCCHC10
Interaction	ASF1A interactions	KMT2A JUN JUND KMT2D CABIN1 MSL3	1.05e-05	249	41	6	int:ASF1A
Interaction	BHLHA15 interactions	RBM23 MYOD1 RBM39 MYOG	1.30e-05	71	41	4	int:BHLHA15
Interaction	JUND interactions	JDP2 JUN JUNB JUND	1.98e-05	79	41	4	int:JUND
Interaction	CREB5 interactions	JDP2 SPRED1 JUN JUNB JUND	1.99e-05	164	41	5	int:CREB5
Interaction	PHF5A interactions	ELP1 SNRNP48 SP110 RBM39 DHX8	2.43e-05	171	41	5	int:PHF5A
Interaction	SRSF4 interactions	KMT2A SRSF4 RBM23 RBM39 SON DHX8	3.00e-05	300	41	6	int:SRSF4
Interaction	BTG1 interactions	JUN MYOD1 MYOG	3.05e-05	30	41	3	int:BTG1
Interaction	NKTR interactions	SRSF4 RBM39 SON DHX8	3.32e-05	90	41	4	int:NKTR
Interaction	BATF2 interactions	JUN JUNB EPAS1	3.38e-05	31	41	3	int:BATF2
Interaction	SRPK3 interactions	DDX56 SRSF4 RBM23 RBM39 SON	4.02e-05	190	41	5	int:SRPK3
Interaction	JUN interactions	JDP2 JUN JUNB JUND MYOD1 RBM39 EPAS1	4.06e-05	470	41	7	int:JUN
Interaction	LINC02910 interactions	PRPF38B RSRC2 RBM23 RSRC1	4.11e-05	95	41	4	int:LINC02910
Interaction	MYOD1 interactions	JUN IFRD1 KMT2D CABIN1 MYOD1	4.44e-05	194	41	5	int:MYOD1
Interaction	PPP3CB interactions	JUN CABIN1 RBM39 RSRC1	4.64e-05	98	41	4	int:PPP3CB
Interaction	DDX23 interactions	DDX56 SRSF4 RSRC2 RBM39 EPAS1 RSRC1 DHX8	4.64e-05	480	41	7	int:DDX23
Interaction	SRSF11 interactions	PRPF38B SRSF4 RBM39 SON DHX8	5.51e-05	203	41	5	int:SRSF11
Interaction	HDAC1 interactions	SFMBT1 JDP2 KMT2A JUN IFRD1 KMT2D CABIN1 MYOD1 RBM39 EPAS1	5.69e-05	1108	41	10	int:HDAC1
Interaction	SRRM4 interactions	SRSF4 RBM39 RSRC1	5.79e-05	37	41	3	int:SRRM4
Interaction	CENPQ interactions	JUN JUNB JUND SRSF4	6.78e-05	108	41	4	int:CENPQ
Interaction	SNRPB interactions	JUN SNRNP48 SRSF4 RBM39 RSRC1 SON DHX8	7.41e-05	517	41	7	int:SNRPB
Interaction	SMARCB1 interactions	KMT2A JUN CABIN1 MYOD1 EPAS1 SON	8.78e-05	364	41	6	int:SMARCB1
Interaction	JUNB interactions	JDP2 JUN JUNB JUND	9.57e-05	118	41	4	int:JUNB
Interaction	UTP14A interactions	DDX56 SNRNP48 DHX37 RBM39 RSRC1	9.94e-05	230	41	5	int:UTP14A
Interaction	NFE2L1 interactions	JUN JUNB JUND	1.05e-04	45	41	3	int:NFE2L1
Interaction	PAXBP1 interactions	SRSF4 RBM39 RSRC1 DHX8	1.05e-04	121	41	4	int:PAXBP1
Interaction	MED8 interactions	ELP1 KMT2A MYOD1 EPAS1	1.05e-04	121	41	4	int:MED8
Interaction	SIRT7 interactions	ELP1 KMT2A DDX56 SRSF4 DHX37 RBM39 SON DHX8	1.08e-04	744	41	8	int:SIRT7
Interaction	FBXW7 interactions	ELP1 KMT2A FAM91A1 SPRED1 JUN PRPF38B KMT2D SRSF4 ARHGEF10 RBM39	1.23e-04	1215	41	10	int:FBXW7
Interaction	FOSB interactions	JUN JUNB JUND	1.35e-04	49	41	3	int:FOSB
Interaction	H2BC8 interactions	KMT2A DDX56 RSRC2 HIRIP3 DHX37 DHX8 MSL3	1.45e-04	576	41	7	int:H2BC8
Interaction	CEBPA interactions	JDP2 KMT2A JUN JUNB JUND PRPF38B KMT2D RSRC2 SP110 RBM39	1.50e-04	1245	41	10	int:CEBPA
Interaction	KMT2C interactions	KMT2A JUN KMT2D MYOD1	1.56e-04	134	41	4	int:KMT2C
Interaction	SETD2 interactions	ARHGEF10 SP110 RBM39 DHX8	1.61e-04	135	41	4	int:SETD2
Interaction	MAPK8 interactions	ELP1 JDP2 JUN JUNB JUND	1.70e-04	258	41	5	int:MAPK8
Interaction	UQCR11 interactions	PRPF38B RSRC2 RSRC1	1.71e-04	53	41	3	int:UQCR11
Interaction	SIRT1 interactions	JUN DDX56 JUND SP110 MYOD1 EPAS1	1.73e-04	412	41	6	int:SIRT1
Interaction	CREBBP interactions	JDP2 KMT2A JUN JUNB KMT2D MYOD1 EPAS1	1.85e-04	599	41	7	int:CREBBP
Interaction	DOT1L interactions	KMT2A DDX56 JUND SRSF4 RBM39 RSRC1 SON DHX8	1.88e-04	807	41	8	int:DOT1L
Interaction	AHCYL2 interactions	JUN RBM23 ARSI DHX8	2.12e-04	145	41	4	int:AHCYL2
Interaction	NCOA6 interactions	KMT2A JUN KMT2D RBM39	2.12e-04	145	41	4	int:NCOA6
Interaction	SMAD3 interactions	JUN JUNB JUND MYOD1 EPAS1 DHX8	2.68e-04	447	41	6	int:SMAD3
Interaction	NCBP3 interactions	SRSF4 RBM39 RSRC1 MSL3	2.80e-04	156	41	4	int:NCBP3
Interaction	ATF7 interactions	JDP2 JUN JUNB	2.85e-04	63	41	3	int:ATF7
Interaction	MKI67 interactions	KMT2A DDX56 KMT2D SRSF4 RBM39 SON MAP3K14	2.98e-04	648	41	7	int:MKI67
Interaction	DHX8 interactions	SRSF4 RSRC2 RBM39 SON DHX8	3.02e-04	292	41	5	int:DHX8
Interaction	RAD18 interactions	JUNB PRPF38B SNRNP48 SRSF4 HIRIP3 SP110	3.02e-04	457	41	6	int:RAD18
Interaction	CEBPG interactions	JDP2 JUN JUND	3.13e-04	65	41	3	int:CEBPG
Interaction	ATF1 interactions	CREBRF JUN JUNB	3.13e-04	65	41	3	int:ATF1
Interaction	IFI27L1 interactions	PRPF38B RSRC2 RSRC1	3.13e-04	65	41	3	int:IFI27L1
Interaction	ZC3H18 interactions	DDX56 PRPF38B SRSF4 RSRC2 RBM39 RSRC1 SON DHX8	3.31e-04	877	41	8	int:ZC3H18
Interaction	HIRA interactions	JUN JUND HIRIP3 CABIN1	3.46e-04	165	41	4	int:HIRA
Interaction	SRSF5 interactions	KMT2A DDX56 SRSF4 DHX37 SON MAP3K14	3.67e-04	474	41	6	int:SRSF5
Interaction	ETV4 interactions	JUN KMT2D EPAS1	3.73e-04	69	41	3	int:ETV4
Interaction	FOSL1 interactions	JUN JUNB JUND	3.89e-04	70	41	3	int:FOSL1
Interaction	FOS interactions	JUN JUNB JUND KMT2D EPAS1	4.09e-04	312	41	5	int:FOS
Interaction	EGR1 interactions	JUN JUNB JUND	4.23e-04	72	41	3	int:EGR1
Interaction	TOP1 interactions	KMT2A JUN DDX56 SNRNP48 RBM39 SON DHX8	4.59e-04	696	41	7	int:TOP1
Interaction	UBN1 interactions	JUN JUND CABIN1	5.15e-04	77	41	3	int:UBN1
Interaction	IFI16 interactions	JUN DDX56 SRSF4 DHX37 RBM39 SON DHX8	5.35e-04	714	41	7	int:IFI16
Interaction	FIGLA interactions	MYOD1 MYOG	5.39e-04	17	41	2	int:FIGLA
Interaction	MAPK9 interactions	JDP2 JUN JUNB JUND	5.45e-04	186	41	4	int:MAPK9
Interaction	CDX1 interactions	CABIN1 RBM23 DHX8	5.76e-04	80	41	3	int:CDX1
Interaction	FOSL2 interactions	JUN JUNB JUND	6.41e-04	83	41	3	int:FOSL2
Interaction	CLK2 interactions	SRSF4 HIRIP3 RBM39 SON	6.51e-04	195	41	4	int:CLK2
Interaction	PGR interactions	JDP2 RBM23 RBM39	6.64e-04	84	41	3	int:PGR
Interaction	SRRM1 interactions	KMT2D SRSF4 RBM23 RBM39 DHX8	6.71e-04	348	41	5	int:SRRM1
Interaction	HECTD1 interactions	DDX56 PRPF38B ARHGEF10 PCDH10 DHX37 RBM39 SON DHX8	7.12e-04	984	41	8	int:HECTD1
Interaction	SNRNP70 interactions	DDX56 PRPF38B SRSF4 RSRC2 RBM39 RSRC1 SON DHX8	7.12e-04	984	41	8	int:SNRNP70
Interaction	NFATC2 interactions	JUN JUNB JUND CABIN1	7.15e-04	200	41	4	int:NFATC2
Interaction	MEF2D interactions	JUN KMT2D CABIN1	7.36e-04	87	41	3	int:MEF2D
Interaction	NHLH1 interactions	KMT2A DDX56 KMT2D	7.61e-04	88	41	3	int:NHLH1
Interaction	SON interactions	SRSF4 RBM39 SON DHX8	8.28e-04	208	41	4	int:SON
Interaction	SP1 interactions	KMT2A JUN MYOD1 MYOG EPAS1	8.32e-04	365	41	5	int:SP1
Interaction	SOX10 interactions	JUN KMT2D EPAS1	8.66e-04	92	41	3	int:SOX10
Interaction	ATF3 interactions	JUN JUNB JUND	9.21e-04	94	41	3	int:ATF3
Interaction	RBM23 interactions	SRSF4 RBM23 RBM39	9.21e-04	94	41	3	int:RBM23
Interaction	MECP2 interactions	DDX56 PRPF38B SNRNP48 SRSF4 RSRC2 DHX37 RBM39 SON DHX8	9.36e-04	1287	41	9	int:MECP2
Interaction	TLE3 interactions	KMT2A JUND KMT2D MYOD1 SON	9.50e-04	376	41	5	int:TLE3
Interaction	MEN1 interactions	KMT2A DDX56 JUND KMT2D SRSF4 DHX37 SON DHX8	9.54e-04	1029	41	8	int:MEN1
Interaction	CENPA interactions	KMT2A FAM91A1 DDX56 HIRIP3 DHX37	9.61e-04	377	41	5	int:CENPA
Interaction	SRSF1 interactions	DDX56 SRSF4 RBM39 RSRC1 SON DHX8	9.66e-04	570	41	6	int:SRSF1
Interaction	ID4 interactions	MYOD1 MYOG	9.94e-04	23	41	2	int:ID4
Interaction	CLK3 interactions	PRPF38B SRSF4 HIRIP3 RBM39	1.02e-03	220	41	4	int:CLK3
Interaction	ATF4 interactions	JDP2 JUN JUNB	1.04e-03	98	41	3	int:ATF4
Interaction	CSRP3 interactions	MYOD1 MYOG	1.08e-03	24	41	2	int:CSRP3
Cytoband	5q32	ABLIM3 ARSI	1.08e-03	54	41	2	5q32
Cytoband	12q24.31	RSRC2 DHX37	2.35e-03	80	41	2	12q24.31
Cytoband	Ensembl 112 genes in cytogenetic band chr5q32	ABLIM3 ARSI	2.35e-03	80	41	2	chr5q32
GeneFamily	Basic leucine zipper proteins\|Jun transcription factor family	JUN JUNB JUND	2.64e-09	3	26	3	1257
GeneFamily	Basic leucine zipper proteins	JDP2 JUN JUNB JUND	6.81e-07	49	26	4	506
GeneFamily	DEAH-box helicases	DHX37 DHX8	2.36e-04	16	26	2	500
GeneFamily	PHD finger proteins	KMT2A KMT2D SP110	2.85e-04	90	26	3	88
GeneFamily	Basic helix-loop-helix proteins	MYOD1 MYOG EPAS1	5.14e-04	110	26	3	420
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2A KMT2D	1.08e-03	34	26	2	487
GeneFamily	Endogenous ligands\|Minor histocompatibility antigens	SP110 SON	2.43e-03	51	26	2	870
GeneFamily	RNA binding motif containing	SRSF4 RBM23 RBM39	3.43e-03	213	26	3	725
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_ENDOTHELIAL_CELL_OF_CORONARY_ARTERY_AGEING	JUN JUNB JUND ABLIM3 RBM39 EPAS1 SON	1.01e-07	246	41	7	MM3713
Coexpression	TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_BETA_CELL_AGEING	JUN JUNB JUND RSRC2 RBM39 SON	9.26e-07	212	41	6	MM3816
Coexpression	CHEN_HOXA5_TARGETS_9HR_UP	JUN JUNB PRPF38B IFRD1 RSRC2 RBM39	1.24e-06	223	41	6	M17621
Coexpression	PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN	JUN JUND IFRD1 RSRC2 SON	2.34e-06	137	41	5	M4781
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	CREBRF ELP1 KMT2A JUNB JUND PRPF38B KMT2D RSRC2 SP110 RBM39 SON	1.27e-05	1492	41	11	M40023
Coexpression	TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_DELTA_CELL_AGEING	JUN JUNB JUND RSRC2 RBM39	1.47e-05	200	41	5	MM3817
Coexpression	AMIT_EGF_RESPONSE_60_MCF10A	JUN JUNB MAP3K14	3.12e-05	39	41	3	M6815
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SFMBT1 JUN IFRD1 ABLIM3 ARHGEF10 RBM39 SON MAP3K14	4.60e-05	856	41	8	M4500
Coexpression	TABULA_MURIS_SENIS_LIVER_MYELOID_LEUKOCYTE_AGEING	JUNB JUND IFRD1	5.15e-05	46	41	3	MM3755
Coexpression	TURJANSKI_MAPK8_AND_MAPK9_TARGETS	JUN JUND	6.64e-05	8	41	2	M9841
Coexpression	BUSSLINGER_DUODENAL_IMMUNE_CELLS	KMT2A JUN JUNB JUND PRPF38B SP110 RBM39 SON	7.12e-05	911	41	8	M40038
Coexpression	TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_ALPHA_CELL_AGEING	JUN JUNB JUND RBM39	7.16e-05	142	41	4	MM3815
Coexpression	AUNG_GASTRIC_CANCER	JUN IFRD1 KMT2D	7.44e-05	52	41	3	M4322
Coexpression	TABULA_MURIS_SENIS_LIVER_NK_CELL_AGEING	JUN JUNB IFRD1 RSRC2 RBM39	8.39e-05	288	41	5	MM3751
Coexpression	CHASSOT_SKIN_WOUND	JUN JUNB	8.53e-05	9	41	2	M13038
Coexpression	STK33_NOMO_UP	CREBRF SPRED1 JUN JUNB EPAS1	8.66e-05	290	41	5	M2855
Coexpression	GARY_CD5_TARGETS_UP	CREBRF JUNB JUND IFRD1 RBM39 RSRC1	8.81e-05	473	41	6	M17693
Coexpression	TABULA_MURIS_SENIS_HEART_AND_AORTA_SMOOTH_MUSCLE_CELL_AGEING	JUN JUNB JUND	9.80e-05	57	41	3	MM3716
Coexpression	GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP	KMT2A JUN RSRC2	1.09e-04	59	41	3	M17730
Coexpression	DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN	CREBRF JUN JUNB ABLIM3 EPAS1 MAP3K14	1.25e-04	504	41	6	M2157
Coexpression	DIRMEIER_LMP1_RESPONSE_EARLY	JUN JUNB JUND	1.26e-04	62	41	3	M13941
Coexpression	YAMAZAKI_TCEB3_TARGETS_UP	JUND PRPF38B EPAS1 MSL3	1.31e-04	166	41	4	M1542
Coexpression	NAGASHIMA_NRG1_SIGNALING_UP	JUN JUNB IFRD1 MAP3K14	1.50e-04	172	41	4	M11585
Coexpression	MARKS_ACETYLATED_NON_HISTONE_PROTEINS	JUN MYOD1	1.56e-04	12	41	2	M1160
Coexpression	YAMAZAKI_TCEB3_TARGETS_UP	JUND PRPF38B EPAS1 MSL3	1.75e-04	179	41	4	MM660
Coexpression	BAE_BRCA1_TARGETS_UP	JUND IFRD1 EPAS1	1.89e-04	71	41	3	M2072
Coexpression	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS	JUN JUND	2.15e-04	14	41	2	MM1251
Coexpression	ZAIDI_OSTEOBLAST_TRANSCRIPTION_FACTORS	JUN JUND	2.15e-04	14	41	2	M6267
Coexpression	JIANG_MELANOMA_TRM5_CD8	JUNB JUND IFRD1 RSRC2	2.15e-04	189	41	4	M48969
Coexpression	GSE29617_CTRL_VS_TIV_FLU_VACCINE_PBMC_2008_UP	CREBRF JUNB JUND SRSF4	2.24e-04	191	41	4	M4926
Coexpression	GSE34156_NOD2_LIGAND_VS_TLR1_TLR2_LIGAND_24H_TREATED_MONOCYTE_UP	SFMBT1 JUN KMT2D DPPA2	2.24e-04	191	41	4	M8671
Coexpression	GSE21927_HEALTHY_VS_TUMOROUS_BALBC_MOUSE_MONOCYTE_UP	ARHGEF10 RBM39 RSRC1 SON	2.29e-04	192	41	4	M7558
Coexpression	GSE37416_CTRL_VS_6H_F_TULARENSIS_LVS_NEUTROPHIL_UP	ELP1 FAM91A1 PRPF38B MSL3	2.52e-04	197	41	4	M5332
Coexpression	GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN	FAM91A1 DAAM2 SPRED1 ABLIM3	2.57e-04	198	41	4	M7228
Coexpression	MANNO_MIDBRAIN_NEUROTYPES_BASAL	RSRC2 RBM39 SON	2.59e-04	79	41	3	M39048
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	KMT2A RSRC2 SON MSL3	2.62e-04	199	41	4	M7596
Coexpression	GSE29949_MICROGLIA_BRAIN_VS_CD8_POS_DC_SPLEEN_UP	ELP1 JUN DHX8 MSL3	2.62e-04	199	41	4	M8396
Coexpression	GSE12845_IGD_POS_BLOOD_VS_NAIVE_TONSIL_BCELL_DN	JUN RSRC2 CABIN1 RBM23	2.62e-04	199	41	4	M3186
Coexpression	GSE10239_MEMORY_VS_DAY4.5_EFF_CD8_TCELL_UP	KMT2A JUN SP110 MAP3K14	2.62e-04	199	41	4	M3073
Coexpression	GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN	KMT2D CABIN1 SP110 SON	2.67e-04	200	41	4	M5063
Coexpression	GSE23308_WT_VS_MINERALCORTICOID_REC_KO_MACROPHAGE_DN	JDP2 SPRED1 JUNB SP110	2.67e-04	200	41	4	M7740
Coexpression	GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP	KMT2A SNRNP48 PCDH10 SON	2.67e-04	200	41	4	M8264
Coexpression	GSE46606_UNSTIM_VS_CD40L_IL2_IL5_1DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN	JDP2 JUN IFRD1 KMT2D	2.67e-04	200	41	4	M9830
Coexpression	GSE2770_UNTREATED_VS_IL12_TREATED_ACT_CD4_TCELL_6H_UP	JDP2 JUNB IFRD1 ARHGEF10	2.67e-04	200	41	4	M6092
Coexpression	GSE2770_IL4_ACT_VS_ACT_CD4_TCELL_2H_DN	JUNB PRPF38B IFRD1 MAP3K14	2.67e-04	200	41	4	M6095
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_2H_BMDC_UP	KMT2A JUN DHX8 MAP3K14	2.67e-04	200	41	4	M3830
Coexpression	SHEPARD_CRASH_AND_BURN_MUTANT_UP	JDP2 JUN JUNB MYOG	2.93e-04	205	41	4	M10828
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN	SFMBT1 ARHGEF10 SON	3.10e-04	84	41	3	M13008
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN	SFMBT1 ARHGEF10 SON	3.21e-04	85	41	3	M10575
Coexpression	TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING	JUNB JUND IFRD1 MAP3K14	3.77e-04	219	41	4	MM3826
Coexpression	HUI_MAPK14_TARGETS_UP	JUN JUND	4.01e-04	19	41	2	M1289
Coexpression	BLANCO_MELO_BRONCHIAL_EPITHELIAL_CELLS_INFLUENZA_A_DEL_NS1_INFECTION_UP	JUN JUNB IFRD1 SP110 ARSI MAP3K14	4.65e-04	644	41	6	M34026
Coexpression	HUI_MAPK14_TARGETS_UP	JUN JUND	4.92e-04	21	41	2	MM543
Coexpression	CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP	JUN IFRD1 ABLIM3 MAP3K14	5.24e-04	239	41	4	M4716
Coexpression	TIAN_TNF_SIGNALING_NOT_VIA_NFKB	JUN JUNB	5.41e-04	22	41	2	M14666
Coexpression	NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN	CREBRF JUND IFRD1 RBM39 SON DHX8	6.19e-04	680	41	6	M41089
Coexpression	ZHANG_INTERFERON_RESPONSE	IFRD1 SP110	6.45e-04	24	41	2	M3559
Coexpression	BENPORATH_NANOG_TARGETS	SPRED1 JUN SRSF4 RSRC2 RBM39 SON MSL3	7.75e-04	988	41	7	M6616
Coexpression	WONG_ADULT_TISSUE_STEM_MODULE	CREBRF KMT2A JUN JUNB JUND ARHGEF10	8.40e-04	721	41	6	M1999
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	KMT2A JUN JUND RSRC2 SP110 RBM39 SON	6.11e-10	200	41	7	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	droplet-Bladder-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND RSRC2 RBM39 SON	1.90e-08	187	41	6	663991a8afe652e92363b64bcbd68c14d0307f0e
ToppCell	droplet-Tongue-nan\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUND PRPF38B RSRC2 RBM39 SON	1.96e-08	188	41	6	d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd
ToppCell	Severe-B_activate-7\|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CREBRF JUN JUNB JUND SP110 RBM23	2.08e-08	190	41	6	67e6c8a5a8724bdf2861fd76a711319dfc71d47a
ToppCell	10x3'2.3-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	CREBRF JUN JUNB JUND IFRD1 RSRC2	2.58e-08	197	41	6	f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed
ToppCell	moderate-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KMT2A JUN JUNB PRPF38B RBM39 SON	2.66e-08	198	41	6	0a868098b1ee4b28b2149ed766acb09e9c0ce14c
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KMT2A JUND RSRC2 SP110 RBM39 SON	2.83e-08	200	41	6	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-nan\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND PCDH10 SON	4.46e-07	167	41	5	b94e8ee8c3fcebedd8fcd719eadddc04c7513c50
ToppCell	Basal-basal-3\|World / Class top	JUN JUNB JUND IFRD1 EPAS1	5.62e-07	175	41	5	a0d7ced5204a9efbbb91ac99410a088f8ed2df0f
ToppCell	droplet-Spleen-nan-18m\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND RSRC2 RBM39	6.83e-07	182	41	5	eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c
ToppCell	HSPCs-Ery/Mk_prog.\|HSPCs / Lineage and Cell class	JUN JUNB JUND IFRD1 RBM39	7.01e-07	183	41	5	59cfb02143b6b54dfca7560562e064948f0340ca
ToppCell	droplet-Spleen-nan-18m-Lymphocytic\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND RSRC2 RBM39	7.01e-07	183	41	5	28cbf909424f3be4491d49832f0aca0386560814
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-nan\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND RSRC2 RBM39	7.01e-07	183	41	5	3fa608aa6b119869ec3280dc388dfee57160e63a
ToppCell	PBMC-Mild-cDC_8\|Mild / Compartment, Disease Groups and Clusters	JUN JUNB JUND IFRD1 RSRC2	7.40e-07	185	41	5	891b39c20fe9858fbba90d9ef7a253f1a0870211
ToppCell	(00)_Basal-(4)_1wkpi\|(00)_Basal / shred by cell type and Timepoint	JUN JUNB JUND RBM39 EPAS1	7.40e-07	185	41	5	bf82ba905e5eee1c39a2731702071d3de10a78b8
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND RBM39 SON	8.01e-07	188	41	5	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	JUN JUNB JUND IFRD1 SRRM3	8.89e-07	192	41	5	3f925a80b5e2b0577d573e88598a2984a5f6a789
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	JUN JUNB JUND IFRD1 MAP3K14	9.12e-07	193	41	5	dbf0fe496254320c894568c31e5f9ce63707d1b5
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	JUNB JUND RSRC2 SP110 RBM39	9.12e-07	193	41	5	7256a5a491536c525b31ae96d47ab5c6303cb73a
ToppCell	PND01\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CREBRF JUN JUNB JUND IFRD1	9.12e-07	193	41	5	c291345c11cfcbceacbdc001a5851f67478a2779
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_2\|COVID-19_Severe / Disease condition and Cell class	CREBRF JDP2 DAAM2 JUNB ABLIM3	9.35e-07	194	41	5	9a9dd34c2e1da1c67c3d9ba99b329966cb9f41d1
ToppCell	Mild/Remission\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	CREBRF JUND SP110 RBM39 SON	9.84e-07	196	41	5	71603a3b7df40eb3f267345f55e44a812fea7926
ToppCell	Control-Classical_Monocyte-cMono_2\|Classical_Monocyte / Disease condition and Cell class	JUN JUNB JUND RBM39 SON	1.01e-06	197	41	5	eb7610c9496a95a5fd866e16abcbc39b83abe617
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	JUNB JUND RSRC2 SP110 RBM39	1.01e-06	197	41	5	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	JUN JUNB JUND RSRC2 RBM39	1.03e-06	198	41	5	5f465cf5c7493e32d9afe9e9d05757d0a95acc33
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	JUN JUNB JUND RSRC2 RBM39	1.03e-06	198	41	5	77ce3fe1ab161c0faf8987e73a64ab61294b9255
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	JUNB JUND RSRC2 SP110 RBM39	1.03e-06	198	41	5	44417089b62056269cac38d3134ff209c05b7007
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	JUNB JUND RSRC2 SP110 RBM39	1.03e-06	198	41	5	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	Mild/Remission-B_naive-13\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUN JUNB JUND IFRD1	8.80e-06	142	41	4	49873a2d9b1ae4bdbf253d1c09bf8845cc0cc917
ToppCell	Mild/Remission-B_naive-13\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUN JUNB JUND IFRD1	9.55e-06	145	41	4	7827aef87f834cd0d19780417757c9386e19b22e
ToppCell	P28\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JUN JUNB JUND EPAS1	1.71e-05	168	41	4	4ee59a6147bbe7e4a03cc2d6fe9d6c10b18a3a06
ToppCell	P15\|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	JUN JUNB EPAS1 SON	1.83e-05	171	41	4	155e7abd52b84d16146001f6ca49ca0c2294a823
ToppCell	Severe-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUNB JUND SP110 RBM23	1.83e-05	171	41	4	61205a4986c2d0a89aea96ed8dec9e952eeb6ff1
ToppCell	(03)_Secretory-(4)_1wkpi\|(03)_Secretory / shred by cell type and Timepoint	JUN JUNB JUND EPAS1	2.00e-05	175	41	4	06b52f85baa31b55bb31477244892b6da79fe2c9
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KMT2A JUN JUNB JUND	2.44e-05	184	41	4	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND EPAS1	2.59e-05	187	41	4	965584ee44669a72866a20ddf7f657bc5a7f7a8b
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND EPAS1	2.59e-05	187	41	4	a7ef179e6561e17cafae10e1843bf82ac3ae0c89
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND EPAS1	2.59e-05	187	41	4	3e25c15fa29f8c738044914e8b3420d5713f18d9
ToppCell	facs-Pancreas-Endocrine-24m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND RBM39	2.71e-05	189	41	4	010fdd70e9d0e21b856306a29ff877776a480319
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4-Trm_Th1/Th17\|Lung / Manually curated celltypes from each tissue	KMT2A JUN JUNB JUND	2.71e-05	189	41	4	f43960506ed3e699e910ec7711c1113e2e9b80d1
ToppCell	facs-Limb_Muscle\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUNB JUND IFRD1 MYOD1	2.71e-05	189	41	4	21ec43859d21ffc565acbe36489da1d2d0f9877d
ToppCell	ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells\|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	KMT2A JUN JUND RBM39	2.71e-05	189	41	4	a0634d72bfdd5f93877724ed6480b50a3a046f71
ToppCell	HSPCs-Ery_prog.\|HSPCs / Lineage and Cell class	JUN JUNB JUND IFRD1	2.71e-05	189	41	4	37d2c45debed1564a40a1085b8b310c50923b9e7
ToppCell	ILEUM\|World / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	JUN JUNB JUND EPAS1	2.76e-05	190	41	4	4395dbd18c14d491f5066a2ddac438a16b1fd7c3
ToppCell	COVID-19_Mild-MAIT\|COVID-19_Mild / Disease condition and Cell class	JUN JUNB JUND IFRD1	2.82e-05	191	41	4	e834d7a6aa7bb4f194b203d351e53bf5d95175d6
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND RBM39	2.82e-05	191	41	4	a251b134f67a0a1ef3a42f50042f128a17f20b22
ToppCell	Mild/Remission-B_activate-7\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUN JUNB JUND SP110	2.82e-05	191	41	4	382686d62f7b8576c44bb9726a4e10dc26fd348e
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4\|Lung / Manually curated celltypes from each tissue	KMT2A JUN JUNB JUND	2.88e-05	192	41	4	fd19cd0b5330448bef8debd753285adbc8b958a2
ToppCell	ASK454\|World / Donor, Lineage and Cell class of Lung cells from Dropseq	JUN JUNB JUND EPAS1	2.88e-05	192	41	4	6b047b445a0df0ecdd6d7baf388a0d966a93b3a2
ToppCell	droplet-Pancreas-Endocrine-18m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND SON	2.88e-05	192	41	4	4510aa262da8dcf7c944b3907a51aba5a9397a4e
ToppCell	facs-Diaphragm\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUNB JUND IFRD1 MYOD1	2.88e-05	192	41	4	486cbf9791ca619e307e8b18aa70ce22111f4f26
ToppCell	PBMC-Control-cDC_6\|Control / Compartment, Disease Groups and Clusters	JUNB JUND IFRD1 RBM39	2.88e-05	192	41	4	41a7201febb7d88a39e4ee64df04cce18c691df8
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature4_(1)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	JDP2 JUNB JUND MAP3K14	2.88e-05	192	41	4	6bba80887d6f64cf913a5c22f62baaddda417ce0
ToppCell	droplet-Pancreas-Endocrine\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND SON	2.88e-05	192	41	4	0dfd1e9896c34aee0f842f8de5d0e3af62a15f68
ToppCell	control-Lymphoid-CTL\|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KMT2A PRPF38B RSRC1 SON	2.94e-05	193	41	4	89d407a88b5956559a589425b89b3eb8dc78e1dd
ToppCell	COVID-19_Severe-Classical_Monocyte-cMono_2\|Classical_Monocyte / Disease condition and Cell class	CREBRF DAAM2 JUNB ABLIM3	2.94e-05	193	41	4	add29b6abdfa49c7f0a0f49841a588d03e3bdb48
ToppCell	Control-B_naive-13\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUN JUNB JUND IFRD1	2.94e-05	193	41	4	2c1fce66ad688f2ec0278fc86afaa1bf107bb9f4
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	SFMBT1 JUNB RBM39 SON	2.94e-05	193	41	4	4e78ddc96d8e403a21c4a303b1f26512d2ac91e8
ToppCell	Control-B_naive-13\|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUN JUNB JUND IFRD1	2.94e-05	193	41	4	32e53a6473a682cf14b20a399c3686f658298b93
ToppCell	droplet-Pancreas-Endocrine-21m\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND SON	3.00e-05	194	41	4	3a3ecedcdc7691cf21775818b598208fcb980c29
ToppCell	10x3'2.3\|World / cell types per 3 fetal stages;per 3',per 5'	JUN JUNB JUND RSRC2	3.00e-05	194	41	4	fc7ed8350ffe1475b8934dfbb107b51991876b0b
ToppCell	droplet-Limb_Muscle-MUSCLE\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSRC2 MYOG EPAS1 SON	3.00e-05	194	41	4	e3d63874111d1e8da3977329426e4dcf68d6de87
ToppCell	PBMC-Severe-cDC_5\|Severe / Compartment, Disease Groups and Clusters	JDP2 JUNB JUND IFRD1	3.00e-05	194	41	4	b903e23eb75733ca516770727097fe74a9f8c1d1
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	JUN JUNB JUND SON	3.00e-05	194	41	4	0b023de48ed8a550d169bbe954881eb04bf4f981
ToppCell	Mild/Remission-B_activate-7\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUN JUNB JUND SP110	3.00e-05	194	41	4	01c97543972159a9468272da06e7e611e2c21fae
ToppCell	T/NK_cells-CD8+_Effector_T_cell\|T/NK_cells / Lineage and Cell class	JUN JUND IFRD1 RBM39	3.06e-05	195	41	4	9bb1281e63daf6aca2817f9cc1f55463b069909f
ToppCell	metastatic_Brain-T/NK_cells-NK\|T/NK_cells / Location, Cell class and cell subclass	JUN JUND IFRD1 RBM39	3.06e-05	195	41	4	184471f71b8bbffec12ebb8dd6a0af589e021c02
ToppCell	mild_COVID-19-MAIT\|mild_COVID-19 / disease group, cell group and cell class (v2)	JUN JUNB JUND IFRD1	3.06e-05	195	41	4	b99815ec94042da1a2574468331b043d29d70b38
ToppCell	mild_COVID-19-MAIT\|World / disease group, cell group and cell class (v2)	JUN JUNB JUND IFRD1	3.06e-05	195	41	4	74f0f709d9b3eed5d7e02a51884f02cc281782f1
ToppCell	Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SFMBT1 SCUBE1 SRRM3 MAP3K14	3.12e-05	196	41	4	614a07334707eafe238d5cb7b080a3ca796a1920
ToppCell	10x5'-Liver-Lymphocytic_T_CD8-Trm/em_CD8\|Liver / Manually curated celltypes from each tissue	KMT2A JUN JUND IFRD1	3.12e-05	196	41	4	91c85ea202508185142ef67af6d27d0932567ca0
ToppCell	severe-B_intermediate\|severe / disease stage, cell group and cell class	JUN JUND IFRD1 SP110	3.12e-05	196	41	4	8f59e51ca50bef4753f67cd1efdb02665805a120
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	CREBRF JUN JUNB JUND	3.12e-05	196	41	4	9a6e4eea19348a6e3379d3b872456ab6280cb74f
ToppCell	3'-Adult-LargeIntestine\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JUN JUNB JUND IFRD1	3.18e-05	197	41	4	03646005921bc330b7a9f66889ef1a7b9a3d530e
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	JUN JUNB JUND IFRD1	3.18e-05	197	41	4	cd54e6ad175529327fa0372033016b3b978dd452
ToppCell	5'-GW_trimst-1.5-LargeIntestine\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	JUN JUNB JUND IFRD1	3.18e-05	197	41	4	0b2ad6a933ff1a325649cc8f139380fd158a1d42
ToppCell	H1299-infected-SARSCoV2\|infected / Cell line, Condition and Strain	PRPF38B RSRC2 DHX37 RBM39	3.18e-05	197	41	4	0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e
ToppCell	COVID-19_Severe-PLT_4\|COVID-19_Severe / Disease Group and Platelet Clusters	CREBRF IFRD1 RSRC2 RBM39	3.24e-05	198	41	4	abfddbee99ef8c7719e6e6f62571e9be030e4acf
ToppCell	Bronchus_Control_(B.)-Immune-TX-B_cells\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	CREBRF JUNB JUND SP110	3.24e-05	198	41	4	6231c44a909dd06f85c8210814e976a5f29148d0
ToppCell	Control-B_intermediate-0\|World / disease group and sub_cluster of B and Plasma cells(res = 0.5)	JUN JUNB JUND SP110	3.24e-05	198	41	4	6f7e0b8bc06368d6e7026d69473ddd42dd41cfcb
ToppCell	kidney_cells-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	KMT2A CABIN1 RBM39 SON	3.31e-05	199	41	4	174f6013af6eafa577f84205a62927f2b367fda3
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD4_INF-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	JUN JUNB JUND SP110	3.31e-05	199	41	4	d3f36ede2fade550ec8f21a0448e71e1ff579ee2
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	JUN JUND RSRC2 RBM39	3.31e-05	199	41	4	dd94e42b62af7cbd69c472681d3c758552694ae2
ToppCell	ASK454-Immune-B_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	JUN JUNB JUND EPAS1	3.31e-05	199	41	4	cbfabf8e895abe454606b990f99e3738f4263ffe
ToppCell	Transverse-T_cell-Th1\|T_cell / Region, Cell class and subclass	JUN JUNB JUND IFRD1	3.31e-05	199	41	4	9271d9d36ffe1c169049d4340258f366916adfaf
ToppCell	Basal-basal-10\|World / Class top	JUN JUNB JUND IFRD1	3.31e-05	199	41	4	4fadfc58102b21bf9db9d0092f3437aa78fddd99
ToppCell	severe\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	JUND RSRC2 RBM39 SON	3.37e-05	200	41	4	accc618d6b960bff30cb531c1226295bfc8650f6
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate\|6m / Sample Type, Dataset, Time_group, and Cell type.	JUN JUND RSRC2 MYOD1	3.37e-05	200	41	4	7c261e39ac30b318511373ab7302aa53b8b81b9c
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Mesoderm\|1m / Sample Type, Dataset, Time_group, and Cell type.	JUNB IFRD1 ABLIM3 PCDH10	3.37e-05	200	41	4	c0ad32e9dd7f481c2665587fd8bd9fffc2e725f9
ToppCell	Sepsis-Bac-SEP\|Sepsis / Disease, condition lineage and cell class	JUN JUNB JUND RBM39	3.37e-05	200	41	4	1f80e6a49c632b3ba0cdac1225c78e5d6d6d78a5
ToppCell	ILEUM-non-inflamed-(3)_MNP-(3)_moDC\|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	JUND PRPF38B RBM39	2.59e-04	135	41	3	b7a792a7c0c22d8b703509f134115f0e394d7de0
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	JUN JUND MAP3K14	3.46e-04	149	41	3	406a5ccfedbf43543f0346ff7ef3ce1d15c38f29
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	JUN JUND MAP3K14	3.46e-04	149	41	3	34a3075af794052763fc7c4135f3031f89da5caa
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	JUN JUND MAP3K14	3.46e-04	149	41	3	be698ecce34ddbdf57d08082b71268934675e74e
ToppCell	Posterior_cortex-Hematopoietic-MICROGLIA-MI1(C1qb)-Tmem119-MICROGLIA_Microglia.C1qb.Tmem119-Fos_(Microglia)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	JUN JUND MAP3K14	3.46e-04	149	41	3	183c77cc8f23b8406e7241a066cb684470002a3b
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DAAM2 EPAS1 SON	3.74e-04	153	41	3	95b28c5bd10ffb74c0993ebd565038b9818e4bd2
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DAAM2 EPAS1 SON	3.74e-04	153	41	3	b09f8def40a1ea56722f3398f61a036667b61cd9
ToppCell	primary_visual_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DAAM2 EPAS1 SON	3.74e-04	153	41	3	3ab9d55b3db51715c1d61eca142384195ce4b54f
ToppCell	frontal_cortex-Non-neuronal-astrocyte\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DAAM2 EPAS1 SON	4.03e-04	157	41	3	803af734d7f775d294391e2b84e472a732e18cef
ToppCell	frontal_cortex-Non-neuronal-astrocyte-Astro-Astro_Aqp4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	DAAM2 EPAS1 SON	4.03e-04	157	41	3	9aa5304a9704da6dd4eda7d6940494b00e38b2e8
Computational	Genes upregulated in subsets of cells of a given type within various tumors	JUN JUNB JUND	2.86e-04	50	28	3	GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_STRESS
Computational	Genes upregulated in subsets of cells of a given type within various tumors	JUN JUNB JUND	2.86e-04	50	28	3	GAVISH_3CA_METAPROGRAM_EPITHELIAL_STRESS
Computational	Genes in the cancer module 123.	KMT2A JUN JUNB JUND MYOD1	3.92e-04	247	28	5	MODULE_123
Drug	iododimethylarsine	JUN JUNB JUND	4.52e-07	9	41	3	CID000069608
Drug	methylarsine oxide	JUN JUNB JUND	4.52e-07	9	41	3	ctd:C080197
Drug	IBI-C83	JUN JUNB JUND	4.52e-07	9	41	3	CID000068764
Drug	2-oxothiazolidine-4-carboxylic acid	JUN JUNB JUND	4.52e-07	9	41	3	ctd:C029536
Drug	methyloxoarsine	JUN JUNB JUND	1.95e-06	14	41	3	CID000092815
Drug	PCI 5002	CREBRF JDP2 JUN JUNB JUND IFRD1 RSRC2 RBM39 MAP3K14	5.03e-06	735	41	9	ctd:C568608
Drug	Dt-f	JUN JUNB JUND	6.05e-06	20	41	3	CID000657098
Drug	dimethylarsine	JUN JUNB JUND	9.36e-06	23	41	3	ctd:C062856
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A	KMT2A JUN JUNB JUND RSRC2	9.54e-06	159	41	5	4328_UP
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	KMT2A JUN JUNB JUND RSRC2	9.83e-06	160	41	5	5275_UP
Drug	AC1O5U0X	JUN JUNB CABIN1	1.07e-05	24	41	3	CID006440684
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	KMT2A JUN JUNB RSRC2 SON	1.11e-05	164	41	5	3852_UP
Drug	P-38	JDP2 JUN JUNB JUND CABIN1 MYOD1 MYOG MAP3K14	1.15e-05	613	41	8	CID000200878
Drug	delta-tocopherol	JUN JUNB JUND	1.37e-05	26	41	3	ctd:C479072
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 CABIN1 RBM23	1.40e-05	172	41	5	4112_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	SFMBT1 JUNB SRSF4 HIRIP3 RBM23	1.48e-05	174	41	5	6579_DN
Drug	SAHA; Down 200; 10uM; PC3; HT_HG-U133A	SFMBT1 PRPF38B SRSF4 HIRIP3 RBM23	1.52e-05	175	41	5	1220_DN
Drug	quinomethionate	JUNB JUND RBM39	1.54e-05	27	41	3	ctd:C005266
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 DDX56 SRSF4 HIRIP3 RBM23	1.88e-05	183	41	5	4770_DN
Drug	retinoic acid; Up 200; 1uM; MCF7; HG-U133A	JUND HIRIP3 ABLIM3 EPAS1 DHX8	2.62e-05	196	41	5	384_UP
Drug	Dihydroergocristine mesylate [24730-10-7]; Down 200; 5.6uM; MCF7; HT_HG-U133A	JUN ABLIM3 ARHGEF10 SP110 MSL3	2.75e-05	198	41	5	7034_DN
Drug	Cyclopentolate hydrochloride [5870-29-1]; Up 200; 12.2uM; MCF7; HT_HG-U133A	ELP1 JUNB ABLIM3 ARHGEF10 SP110	2.81e-05	199	41	5	6214_UP
Drug	canventol	JUN JUNB	3.15e-05	5	41	2	CID000073256
Drug	IBS008738	MYOD1 MYOG	3.15e-05	5	41	2	ctd:C000588695
Drug	D 203	JUN JUNB	3.15e-05	5	41	2	CID003051464
Drug	torcetrapib	KMT2A SPRED1 JUN JUNB RBM39 RSRC1	3.17e-05	342	41	6	ctd:C483909
Drug	gamma-Tocopherol	JUN JUNB JUND	3.71e-05	36	41	3	ctd:D024504
Drug	pyro-Glu-His-Gly	JUN JUNB	4.72e-05	6	41	2	CID003918406
Drug	green tea extract AR25	JUN JUND	4.72e-05	6	41	2	ctd:C465546
Drug	Mn-Ca	MYOD1 MYOG	6.61e-05	7	41	2	CID000115101
Drug	SB-5	MYOD1 MYOG	6.61e-05	7	41	2	CID000046976
Drug	AC1O5LBK	JUN JUNB JUND MYOD1 MYOG	7.14e-05	242	41	5	CID006436256
Drug	Silicates	JUN JUNB	8.80e-05	8	41	2	ctd:D017640
Drug	ptaquiloside	ABLIM3 PCDH10 MYOD1 MYOG	9.53e-05	133	41	4	ctd:C043680
Drug	AC1L1D59	JUN JUNB DDX56 JUND CABIN1	1.11e-04	266	41	5	CID000002199
Drug	4-amino-5-(4-methylphenyl)-7-(tert-butyl)pyrazolo(3,4-d)pyrimidine	JUN JUNB JUND	1.13e-04	52	41	3	ctd:C108123
Drug	NSC-351324	JUN JUNB JUND	1.26e-04	54	41	3	CID000336564
Drug	WIN 54954	JUN JUNB	1.41e-04	10	41	2	CID000441048
Drug	pimaric acid	JUN JUND	1.41e-04	10	41	2	ctd:C008911
Drug	Azacyclonol [115-46-8]; Up 200; 15uM; MCF7; HT_HG-U133A	JUN JUNB RSRC2 MAP3K14	1.68e-04	154	41	4	1520_UP
Drug	2-[amino-[(2R,3R)-4-(benzylamino)-3-hydroxy-4-oxo-2-sulfanylbutanoyl]amino]acetic acid	MYOD1 MYOG	1.72e-04	11	41	2	CID016122531
Drug	AMFH	MYOD1 MYOG	1.72e-04	11	41	2	CID000086520
Drug	Dronabinol	CREBRF JDP2 JUN JUNB JUND IFRD1 SCUBE1 ABLIM3	1.80e-04	905	41	8	ctd:D013759
Drug	Azaguanine-8 [134-58-7]; Up 200; 26.2uM; PC3; HT_HG-U133A	JUN JUNB JUND SON	1.85e-04	158	41	4	1791_UP
Drug	Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A	KMT2A JUN JUNB RSRC2	1.94e-04	160	41	4	4404_UP
Drug	deoxynivalenol	JUN JUNB JUND	2.00e-04	63	41	3	CID000040024
Drug	Proscillaridin A [466-06-8]; Up 200; 7.6uM; MCF7; HT_HG-U133A	KMT2A JUN JUNB RSRC2	2.04e-04	162	41	4	7340_UP
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; PC3; HT_HG-U133A	JUN JUNB JUND RSRC2	2.04e-04	162	41	4	3771_UP
Drug	2-[amino-[(2R,3R)-4-benzoxy-3-hydroxy-4-keto-2-mercapto-butanoyl]amino]acetic acid	MYOD1 MYOG	2.06e-04	12	41	2	CID016122530
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.09e-04	163	41	4	5594_DN
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; PC3; HT_HG-U133A	KMT2A JUN JUNB JUND	2.19e-04	165	41	4	3770_UP
Drug	Digitoxigenin [143-62-4]; Up 200; 10.6uM; MCF7; HT_HG-U133A	KMT2A JUN JUNB RSRC2	2.19e-04	165	41	4	3275_UP
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	KMT2A JUN JUNB RSRC2	2.19e-04	165	41	4	3851_UP
Drug	Strophanthidin [66-28-4]; Up 200; 9.8uM; PC3; HT_HG-U133A	JUN JUNB JUND RSRC2	2.24e-04	166	41	4	5826_UP
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; PC3; HT_HG-U133A	KMT2A JUN JUNB RSRC2	2.29e-04	167	41	4	6680_UP
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.29e-04	167	41	4	5217_DN
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; MCF7; HT_HG-U133A	JUN JUNB JUND RSRC2	2.29e-04	167	41	4	5640_UP
Drug	Helveticoside [630-64-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A	KMT2A JUN JUNB RSRC2	2.29e-04	167	41	4	6047_UP
Drug	Glucosamine	JUN JUNB JUND RBM39 EPAS1	2.31e-04	311	41	5	ctd:D005944
Drug	Puromycin dihydrochloride [58-58-2]; Up 200; 7.4uM; MCF7; HT_HG-U133A	JUN JUNB IFRD1 MAP3K14	2.34e-04	168	41	4	5310_UP
Drug	Astemizole [68844-77-9]; Up 200; 8.8uM; PC3; HT_HG-U133A	JUN JUNB JUND EPAS1	2.39e-04	169	41	4	4471_UP
Drug	BW-B 70C; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA	JUN JUNB EPAS1 MAP3K14	2.39e-04	169	41	4	1132_UP
Drug	Lycorine hydrochloride [2188-68-3]; Up 200; 12.4uM; MCF7; HT_HG-U133A	KMT2A JUN IFRD1 MAP3K14	2.45e-04	170	41	4	6051_UP
Drug	cyclohexane	JUN JUNB JUND IFRD1	2.45e-04	170	41	4	CID000008078
Drug	Digoxigenin [1672-46-4]; Up 200; 10.2uM; PC3; HT_HG-U133A	KMT2A JUN JUNB RSRC2	2.45e-04	170	41	4	4680_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.50e-04	171	41	4	2777_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.50e-04	171	41	4	6879_DN
Drug	Strophantine octahydrate [11018-89-6]; Up 200; 5.4uM; MCF7; HT_HG-U133A	JUN JUNB JUND RSRC2	2.50e-04	171	41	4	5026_UP
Drug	trifluoperazine dihydrochloride; Up 200; 10uM; MCF7; HT_HG-U133A_EA	ELP1 JUN JUNB JUND	2.56e-04	172	41	4	910_UP
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.56e-04	172	41	4	2330_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.56e-04	172	41	4	6993_DN
Drug	tBuBHQ	JUN JUNB JUND	2.61e-04	69	41	3	CID000002374
Drug	N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide	JUN JUNB JUND MYOG	2.62e-04	173	41	4	ctd:C063509
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.62e-04	173	41	4	4565_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.62e-04	173	41	4	5336_DN
Drug	Proscillaridin A [466-06-8]; Down 200; 7.6uM; MCF7; HT_HG-U133A	ELP1 IFRD1 HIRIP3 SP110	2.62e-04	173	41	4	7340_DN
Drug	HC toxin from Helminthosporium carbonum; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	SFMBT1 SRSF4 HIRIP3 RBM23	2.68e-04	174	41	4	909_DN
Drug	SAHA; Down 200; 10uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.68e-04	174	41	4	5580_DN
Drug	Lanatoside C [17575-22-3]; Up 200; 4uM; MCF7; HT_HG-U133A	KMT2A JUN JUNB RSRC2	2.68e-04	174	41	4	6048_UP
Drug	Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; PC3; HT_HG-U133A	JUN JUNB RSRC2 MAP3K14	2.74e-04	175	41	4	4651_UP
Drug	Trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A_EA	SFMBT1 SRSF4 HIRIP3 RBM23	2.74e-04	175	41	4	1014_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.74e-04	175	41	4	7236_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 JUN SRSF4 RBM23	2.86e-04	177	41	4	5308_DN
Drug	trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.86e-04	177	41	4	7047_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.86e-04	177	41	4	3227_DN
Drug	phorbol-13-acetate	JUN JUNB JUND MYOD1 MYOG	2.87e-04	326	41	5	CID000499953
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.92e-04	178	41	4	1471_DN
Drug	fisetin; Down 200; 50uM; PC3; HG-U133A	JUN SRSF4 RSRC2 SON	2.92e-04	178	41	4	579_DN
Drug	Trichostatin A, Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	SFMBT1 SRSF4 HIRIP3 RBM23	2.92e-04	178	41	4	992_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.92e-04	178	41	4	4710_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 RBM23	2.92e-04	178	41	4	6276_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SFMBT1 SRSF4 CABIN1 RBM23	2.98e-04	179	41	4	6609_DN
Drug	resveratrol; Up 200; 10uM; MCF7; HT_HG-U133A_EA	JUN JUNB JUND SP110	3.04e-04	180	41	4	958_UP
Drug	Mitoxantrone dihydrochloride [70476-82-3]; Down 200; 7.8uM; MCF7; HT_HG-U133A	JUN JUNB IFRD1 SON	3.18e-04	182	41	4	5354_DN
Drug	Primaquine diphosphate [63-45-6]; Up 200; 8.8uM; HL60; HT_HG-U133A	JUN JUNB JUND EPAS1	3.24e-04	183	41	4	1343_UP
Drug	Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A	SFMBT1 JUN IFRD1 SON	3.24e-04	183	41	4	2750_DN
Drug	1-(2-trifluoromethoxyphenyl)-2-nitroethanone	RSRC2 ARHGEF10 DHX37 SON	3.31e-04	184	41	4	ctd:C576882
Drug	NP-L3VS	JUN JUNB JUND	3.34e-04	75	41	3	CID005288713
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SFMBT1 SRSF4 HIRIP3 SON	3.38e-04	185	41	4	5882_DN
Drug	Dextroamphetamine	JUN JUNB JUND IFRD1	3.38e-04	185	41	4	ctd:D003913
Disease	renal carcinoma (biomarker_via_orthology)	JUN JUNB JUND	2.30e-08	5	40	3	DOID:4451 (biomarker_via_orthology)
Disease	tongue squamous cell carcinoma (is_marker_for)	JUN JUNB JUND	1.74e-05	37	40	3	DOID:0050865 (is_marker_for)
Disease	Hodgkin's lymphoma (is_marker_for)	JUN JUNB	4.99e-05	8	40	2	DOID:8567 (is_marker_for)
Disease	oral squamous cell carcinoma (is_marker_for)	JUN JUNB KMT2D	8.66e-05	63	40	3	DOID:0050866 (is_marker_for)
Disease	Petit mal status	JUN JUNB JUND	1.04e-04	67	40	3	C0270823
Disease	Status Epilepticus, Subclinical	JUN JUNB JUND	1.04e-04	67	40	3	C0751522
Disease	Simple Partial Status Epilepticus	JUN JUNB JUND	1.04e-04	67	40	3	C0751524
Disease	Non-Convulsive Status Epilepticus	JUN JUNB JUND	1.04e-04	67	40	3	C0751523
Disease	Grand Mal Status Epilepticus	JUN JUNB JUND	1.04e-04	67	40	3	C0311335
Disease	Complex Partial Status Epilepticus	JUN JUNB JUND	1.04e-04	67	40	3	C0393734
Disease	Status Epilepticus	JUN JUNB JUND	1.09e-04	68	40	3	C0038220
Disease	congenital heart disease (implicated_via_orthology)	KMT2A KMT2D SON	1.14e-04	69	40	3	DOID:1682 (implicated_via_orthology)
Disease	Autosome Abnormalities	KMT2A EPAS1	2.12e-04	16	40	2	C0004403
Disease	Chromosome Aberrations	KMT2A EPAS1	2.12e-04	16	40	2	C0008625
Disease	Hereditary Paraganglioma-Pheochromocytoma Syndrome	KMT2D EPAS1	4.45e-04	23	40	2	C1708353
Disease	colorectal adenocarcinoma (is_marker_for)	JUN JUNB	6.16e-04	27	40	2	DOID:0050861 (is_marker_for)
Disease	Duchenne muscular dystrophy (implicated_via_orthology)	MYOD1 MYOG	1.10e-03	36	40	2	DOID:11723 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
KKRSKSRSKERTRHR	PRPF4B	181	Q13523
RRRRSRSKVKEDKFK	PRPF4B	491	Q13523
KEKSRDAARCRRSKE	EPAS1	16	Q99814
CKQAARAEKKLKHRR	ABLIM3	261	O94929
LRSKARRAKKAKASS	ARHGEF10	1316	O15013
ARSFSRGRRKKKCKI	ARSI	536	Q5FYB1
SRKEKNKLASRACRL	CREBRF	526	Q8IUR6
KKRSRSHNKSRDRKR	RBM23	61	Q86U06
ERKRSKSKERKRSRD	RBM39	46	Q14498
KRSRDRERKKSKSRE	RBM39	56	Q14498
FDKDLCKLKRSRKRS	DAAM2	1036	Q86T65
RRKSAREERSCKQKS	HIRIP3	266	Q9BW71
KSKLRAREKRHQARC	MAGEB18	6	Q96M61
RNRIAASKCRKRKLE	JUN	261	P05412
CRSSKKFFRRKTARD	FAM91A1	141	Q658Y4
AASKCRKRKLERISR	JUND	281	P17535
KRRREKNKVAAARCR	JDP2	76	Q8WYK2
RKKLSSSCRKAKRAK	DDX56	511	Q9NY93
CKRKTTNADRRKAAT	MYOD1	101	P15172
VARLRSTGRKKKRCR	MSL3	91	Q8N5Y2
ARSSKNRRKAERKKH	ELP1	1191	O95163
CGRQARARKKKLSKS	PCDH10	771	Q9P2E7
KRRSARVRNTKCKKE	CABIN1	391	Q9Y6J0
KARTKARSKCRDKRA	IFRD1	431	O00458
SSRDRRQKGKKSCKE	KMT2A	2421	Q03164
KFKKSRARAKKARAE	DHX37	516	Q8IY37
LKCDSSKKRRRGRKS	SCUBE1	526	Q8IWY4
EHRDRTKKKKRSRSR	DHX8	166	Q14562
TKKKKRSRSRDRNRD	DHX8	171	Q14562
CSRKRKAVTKRARLQ	DPPA2	146	Q7Z7J5
RVCWKGKRRSKARKK	MAP3K14	131	Q99558
ERKKSRSRSRERKKS	RSRC2	141	Q7L4I2
ERKKSRSRSRERKKS	RSRC2	151	Q7L4I2
RSRSRSRSKSKDKRK	SRSF4	341	Q08170
KRRHRSRSSKCKRKE	SRRM3	221	A6NNA2
RVQKARTKCARKSRL	SP110	411	Q9HB58
KKSKRRKEDGERSRC	SPRED1	321	Q7Z699
KSRKRSRSKERSHKR	PRPF38B	496	Q5VTL8
ESRSKRKKKHRRRSS	RSRC1	11	Q96IZ7
NLACALKKASKRRKR	SFMBT1	656	Q9UHJ3
RKRNKDKDKNCESRR	SNRNP48	306	Q6IEG0
KKRDSSLRSRSKRSK	SON	1816	P18583
KHRSKSRERKRKRSS	SON	1896	P18583
AATKCRKRKLERIAR	JUNB	281	P17275
RKSRKALCAKQRTAK	KMT2D	3536	O14686
AKQRRSEKKARKARF	NACA4P	66	Q9BZK3
KVCKRKSVSVDRRRA	MYOG	71	P15173